Clinical reference Biomarker Directory
Back to directory

C2

Established

C2 is an early classical-pathway complement protein; its deficiency is the most common inherited complement defect.

Also known as Complement component 2
In plain language

C2 helps trigger the immune system's complement defense cascade. It's the most common inherited complement deficiency and, like other early-pathway deficiencies, raises the risk of both certain infections and lupus-like autoimmune disease.

Biomarker & context

C2 is an early classical complement pathway component that combines with C4b to form C3 convertase, propagating the complement cascade. C2 deficiency is the most common inherited complement deficiency.

What it indicates

C2 deficiency is associated with both increased infection risk from encapsulated organisms and, notably, autoimmune disease — following the general "early complement deficiency = autoimmunity" pattern shared with C1q and C4 deficiency, though the SLE association is somewhat weaker than for C1q or C4.

Diagnosis & clinical testing

Screened via CH50 (classical pathway activity), followed by specific C2 level/functional assay if CH50 is low or undetectable; C2 and C4 deficiencies together are the most commonly identified classical pathway defects.

Guiding treatment

Management centers on vaccination (pneumococcal, meningococcal, Hib), prompt antibiotic treatment of infections, and monitoring for autoimmune disease development.

Clinical significance

Follows the early-complement pattern of increased both infection risk and autoimmune (lupus) risk.

References
  1. ScienceDirect Topics. Complement Deficiency — an overview.
  2. StatPearls. (2023). Complement Deficiency.